HU0104513A3 - Powders of improved quality - Google Patents

Powders of improved quality

Info

Publication number
HU0104513A3
HU0104513A3 HU0104513A HU0104513A HU0104513A3 HU 0104513 A3 HU0104513 A3 HU 0104513A3 HU 0104513 A HU0104513 A HU 0104513A HU 0104513 A HU0104513 A HU 0104513A HU 0104513 A3 HU0104513 A3 HU 0104513A3
Authority
HU
Hungary
Prior art keywords
powders
improved quality
quality
improved
Prior art date
Application number
HU0104513A
Other versions
HU0104513A2 (en
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9827145A priority Critical patent/GB9827145D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to PCT/GB1999/004156 priority patent/WO2000033811A2/en
Publication of HU0104513A2 publication Critical patent/HU0104513A2/en
Publication of HU0104513A3 publication Critical patent/HU0104513A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
HU0104513A 1998-12-09 1999-12-09 Powders of improved quality HU0104513A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9827145A GB9827145D0 (en) 1998-12-09 1998-12-09 Improvements in or relating to powders
PCT/GB1999/004156 WO2000033811A2 (en) 1998-12-09 1999-12-09 Improvements in or relating to powders

Publications (2)

Publication Number Publication Date
HU0104513A2 HU0104513A2 (en) 2002-03-28
HU0104513A3 true HU0104513A3 (en) 2003-12-29

Family

ID=10843948

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104513A HU0104513A3 (en) 1998-12-09 1999-12-09 Powders of improved quality

Country Status (23)

Country Link
US (1) US6989155B1 (en)
EP (1) EP1137399B1 (en)
JP (1) JP4410942B2 (en)
CN (1) CN1334723A (en)
AT (1) AT240093T (en)
AU (1) AU770461B2 (en)
BR (1) BR9916102A (en)
CA (1) CA2353448C (en)
CZ (1) CZ20012043A3 (en)
DE (1) DE69907951T2 (en)
DK (1) DK1137399T3 (en)
EA (1) EA004045B1 (en)
ES (1) ES2198973T3 (en)
GB (1) GB9827145D0 (en)
HU (1) HU0104513A3 (en)
MX (1) MXPA01005584A (en)
NO (1) NO20012825L (en)
NZ (1) NZ511965A (en)
PL (1) PL348831A1 (en)
PT (1) PT1137399E (en)
SK (1) SK284775B6 (en)
TR (1) TR200101591T2 (en)
WO (1) WO2000033811A2 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
DK1808438T3 (en) 1999-06-29 2014-10-27 Mannkind Corp Purification and stabilization of peptide and protein drugs in
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2001151673A (en) * 1999-09-06 2001-06-05 Nikken Chem Co Ltd Production of powdery preparation for inhalation
AU2211802A (en) 2000-11-30 2002-06-11 Vectura Ltd Pharmaceutical compositions for inhalation
EP2283817B1 (en) 2000-11-30 2016-05-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
AT378039T (en) * 2000-06-27 2007-11-15 Vectura Ltd Production method of particles for use in a pharmaceutical composition
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
AT446085T (en) * 2000-11-30 2009-11-15 Vectura Ltd Particles for use in a pharmaceutical composition
AU2003230689B2 (en) * 2002-03-20 2006-06-29 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
WO2003079993A2 (en) * 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
AU2004228757A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK2322180T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for drug delivery
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
ES2613391T3 (en) 2005-02-10 2017-05-24 Glaxo Group Limited Lactose manufacturing processes using presorting techniques and pharmaceutical formulations formed therefrom
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
KR20160022404A (en) 2005-09-14 2016-02-29 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
GB0525254D0 (en) * 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
JP5599975B2 (en) * 2006-02-22 2014-10-01 マンカインド コーポレイション Method for improving the formulation properties of the fine particles containing diketopiperazine and an active agent
DE102006030164A1 (en) * 2006-06-29 2008-01-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhalation powder
DE102006053375A1 (en) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg A method for mixing of powders
US20090048155A1 (en) 2007-08-15 2009-02-19 Endacea, Inc. Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
CA2709772A1 (en) 2007-12-21 2009-07-09 Endacea, Inc. A1 adenosine receptor antagonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (en) 2008-06-13 2018-01-29 Mannkind Corp Dry powder inhaler and system for drug administration
RU2470681C2 (en) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Interactive system and method for real-time force profiling in inhalation
TWI614024B (en) 2008-08-11 2018-02-11 Mannkind Corp Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp An apparatus, system and method for measuring resistance in an inhaler
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
BRPI1013154A2 (en) 2009-06-12 2016-04-05 Mannkind Corp microparticles of diketopiperazine with specific surface areas defined.
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
US9877967B2 (en) 2010-01-26 2018-01-30 Endacea, Inc. Methods and pharmaceutical compositions for preventing and treating renal impairment
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
US20130164338A1 (en) * 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
JP6092113B2 (en) * 2010-11-09 2017-03-08 マンカインド コーポレイション Compositions for migraine treatment, including serotonin receptor agonists and diketopiperazine
AU2015249177B2 (en) * 2010-11-09 2017-08-03 Mannkind Corporation Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
RU2448717C1 (en) * 2011-04-20 2012-04-27 Закрытое акционерное общество Научно-производственное предприятие "Тринита" Method for making anticoagulant-fibrinolytic heparin preparation
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation
CA2907566A1 (en) 2013-04-01 2014-10-09 Pulmatrix, Inc. Tiotropium dry powders
CA2918369A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
KR19980703876A (en) * 1995-04-14 1998-12-05 스티븐 엘. 허스트 The pharmaceutical compositions of the improved dispersibility of powdered
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
NZ518401A (en) * 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity

Also Published As

Publication number Publication date
TR200101591T2 (en) 2001-11-21
AU1577700A (en) 2000-06-26
JP2002531487A (en) 2002-09-24
WO2000033811A2 (en) 2000-06-15
PL348831A1 (en) 2002-06-17
AU770461B2 (en) 2004-02-19
SK7772001A3 (en) 2001-12-03
DE69907951D1 (en) 2003-06-18
JP4410942B2 (en) 2010-02-10
NO20012825L (en) 2001-06-08
DK1137399T3 (en) 2003-08-18
CZ20012043A3 (en) 2001-12-12
PT1137399E (en) 2003-09-30
CA2353448C (en) 2010-02-23
US6989155B1 (en) 2006-01-24
ES2198973T3 (en) 2004-02-01
NO20012825D0 (en) 2001-06-08
EP1137399B1 (en) 2003-05-14
SK284775B6 (en) 2005-11-03
BR9916102A (en) 2001-09-04
AT240093T (en) 2003-05-15
EP1137399A2 (en) 2001-10-04
HU0104513A2 (en) 2002-03-28
GB9827145D0 (en) 1999-02-03
DE69907951T2 (en) 2004-03-11
MXPA01005584A (en) 2003-07-14
EA200100636A1 (en) 2001-12-24
NZ511965A (en) 2003-09-26
CA2353448A1 (en) 2000-06-15
CN1334723A (en) 2002-02-06
WO2000033811A3 (en) 2000-10-12
EA004045B1 (en) 2003-12-25

Similar Documents

Publication Publication Date Title
GB2343815B (en) Digital receiver
GB2355016B (en) Sliding material of copper alloy
GB9803411D0 (en) Novel compounds
HK1071139A1 (en) Intermediate compounds for the preparation of imidazo-pyridine-derivatives
GB9801392D0 (en) Novel compounds
GB2312592A9 (en) Quality of service parameters
PL341642A1 (en) Novel macrolydes
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
GB2346028B (en) Imaging
GB2351868A8 (en) Loudspeakers
IL144003A (en) Derivatives of 3 - phenyl - 4 -
AP1520A (en) Orystalline forms of eto2c-ch2-(R)cgl-aza-pab-ph
TW575403B (en) Vinegar-egg powder's manufacturing process
HK1024632A1 (en) Novel powder compositions
GB9624999D0 (en) Iron-based powder
GB9810193D0 (en) Novel compounds
MXPA00005317A (en) Electrochemical synthesis of perfluoroalkylfluorophosphoranes
PL342469A1 (en) Method of obtaining stilbenic compounds
GB9818959D0 (en) Panelform loudspeaker
PL332850A1 (en) Method of obtaining mixtures of organosilicone-oligosulphanes
GB9808866D0 (en) Novel compounds
GB9807316D0 (en) Loudspeaker
HU0104513A3 (en) Powders of improved quality
GB9826783D0 (en) Inhalation powders
GB9820369D0 (en) Material